TauroLock® catheter locking solution protects your patient from catheter-associated risks. Containing a combination of Heparin, Taurolodine and low concentrations of Citrate, you no longer have to compromise on patency or infection control. TauroLock®  is used to prevent infections in catheter and port systems. Heparin and 4% citrate only have an anticoagulant effect, but no bactericidal properties. Consequently, contamination of the catheter can lead to bacteraemia. Prophylactic use of TauroLock™ prevents the formation of a biofilm and thus improves the patency of the catheter and/or port.

TauroLock™ is the most clinically reviewed catheter locking solution in the market – with over ten years of clinical history, TauroLock meets the requirements set up by the different guidelines in infection prevention as well as uniquely reducing occlusion complications whilst offering a safe alternative to other solutions in the market.

TauroLock™-U25.000 contains substances to ensure patency and provide infection control in the device. It is used with a port or a catheter-based vascular access device. TauroLock™-U25.000 is instilled in the device lumen between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth.

Available from Iskus Health in

  • null
    Republic of Ireland
  • null
    Northern Ireland

Related Downloads